NephroGenex Announces Research Collaborations For Pivotal Studies Of Pyridorin™ In Diabetic Nephropathy

Published: Mar 27, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

RESEARCH TRIANGLE PARK, N.C., March 27, 2014 (GLOBE NEWSWIRE) -- NephroGenex, Inc.(Nasdaq:NRX), a pharmaceutical company focused on the development of therapeutics to treat kidney disease, today announced collaborations with two leading research organizations to conduct the Company's Phase 3 PIONEER (PyrIdOriN in DiabEtic NEphRopathy) study.

Help employers find you! Check out all the jobs and post your resume.

Back to news